Matches in Nanopublications for { ?s ?p "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.
- assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP366088.RAmiK3yWXeITwP2w_ACRddE2BUM1zj1amR2GYOqG3MOmM130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366088.RAmiK3yWXeITwP2w_ACRddE2BUM1zj1amR2GYOqG3MOmM130_provenance.
- NP952439.RAgNec3KSThx1DAs1RmUWrKUV9U0_e8bC3144DRRQlnKA130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952439.RAgNec3KSThx1DAs1RmUWrKUV9U0_e8bC3144DRRQlnKA130_provenance.
- NP952437.RAJ1IouZj73_fAl7LclcyWiGY6WMYglIxDBAOcZognzTQ130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952437.RAJ1IouZj73_fAl7LclcyWiGY6WMYglIxDBAOcZognzTQ130_provenance.